chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombosis, Vision blurred
Clinical narrative: Narrative: Patient reports no signs and symptoms currently from the vaccine. Patient instructed to monitor for the following symptoms over the course of three weeks after the vaccination. *A headache that occurs 6 days or more after vaccination * A headache that is different from other headaches you have had * Confusion or trouble thinking clearly * Visual changes, such as blurry vision * Weakness, numbness, or trouble moving one or move parts of your body of your body, trouble speaking or seizures * Tiny spots under the skin away from the area where you have the infection (this is a sign of low platelets) Patient instructed to contact their health care provider if one or more of these symptoms develop. If symptoms are severe, seek immediate medical attention at the closest emergency department or call 9-1-1 **** Patient answered phone very short of breath. He had his wife talk on the phone for him. Wife stated that he had been in the hospital for COVID-19 with dx of DVT, and bilat PE's prior to receiving the vaccine. She stated he is on blood thinners and has concerns about his recent blood clots and the potential of additional blood clots from the vaccine. She stated that he has some confusion and trouble thinking but it has been like that since he had COVID and does not know if there would be a change with the vaccine. Patient has appointment with PCP tomorrow @ 1100. Patient and wife will discuss further with PCP of their concerns. Patients wife advised that if there are any changes or any increased SOB she is to call 911 or go to the closest emergency department
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Bundle branch block right, Chest X-ray abnormal, Cough, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: Narrative:  79-year-old female with a past medical history of hypertension, morbid obesity, COPD and tobacco abuse/dependence who presented to the hospital with a chief complaint of shortness of breath and cough. Patient states she started feeling bad last week and states that it all started with a cough. Patient states she came to emergency department because she was having more difficulty breathing. Patient was noted to be satting in the 90s on arrival to the emergency department but did drop to 87% with ambulation. Patient was also noted to have significant rhonchi and wheezing at the bedside so we were consulted for admission. Patient states she has been vaccinated.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Oxygen saturation decreased, Pleural effusion, Rhonchi, Ventricular extrasystoles
Clinical narrative: Narrative:  79-year-old female with a past medical history of hypertension, morbid obesity, COPD and tobacco abuse/dependence who presented to the hospital with a chief complaint of shortness of breath and cough. Patient states she started feeling bad last week and states that it all started with a cough. Patient states she came to emergency department because she was having more difficulty breathing. Patient was noted to be satting in the 90s on arrival to the emergency department but did drop to 87% with ambulation. Patient was also noted to have significant rhonchi and wheezing at the bedside so we were consulted for admission. Patient states she has been vaccinated.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Narrative:  79-year-old female with a past medical history of hypertension, morbid obesity, COPD and tobacco abuse/dependence who presented to the hospital with a chief complaint of shortness of breath and cough. Patient states she started feeling bad last week and states that it all started with a cough. Patient states she came to emergency department because she was having more difficulty breathing. Patient was noted to be satting in the 90s on arrival to the emergency department but did drop to 87% with ambulation. Patient was also noted to have significant rhonchi and wheezing at the bedside so we were consulted for admission. Patient states she has been vaccinated.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Throat tightness
Clinical narrative: Narrative:  Patient developed shortness of breath, constriction feeling in throat.  stated felt like he needed an inhaler. This occurred shortly after receiving first dose of Moderna covid vaccine. Patient received Albuterol inhaler for treatment and was discharged home. He was instructed not to receive a second dose of moderna vaccine.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Influenza, Pyrexia
Clinical narrative: Fever shortness of breath, burning chest pain,  Narrative: Historically had MI age 31, Symptoms started 2 days after first dose and lasted about 5 days. Flu symptoms after second dose.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID INFECTION FOLLOWING COMPLETION OF COVID-19 VACCINE SERIES 02/26 COVID vaccine dose #1 03/19 COVID vaccine dose #2 04/16 tested for COVID due to planned travel, no symptoms related to COVID, COVID PCR test positive 04/17 test for COVID at facility and received negative Ag results Advised to quarantine and postponed travel to 5/10
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Monitor for addition time, no distress  noted.
Age: 99.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Arthralgia, Mental status changes, Renal failure
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 97 went to the hospital the week of 3/15/21 for knee pain. When he came home his mental status was altered requiring readmission where he was diagnosed with kidney failure and sent home on hospice.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fall, Nausea, Nodule
Clinical narrative: Narrative:  Daughter states that Patient has been falling, with severe dizziness, and nausea, since receiving the J&J covid vaccine on 4.6. Daughter sates that she just wants to know when the SX will stop. Patient fell the other day at the restaurant, but refused medical treatment, now has a "knot" on his head. Transferred call to RN, to discuss further. Previous note from 4/16 states Patient has been having instability for several months.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for COVID-19 and was hospitalized despite full vaccination (Pfizer dose 1 and 2). No booster or 3rd dose received. Date of vaccination #2 was 2/27/21.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asymptomatic COVID-19, Bacterial test negative, Bladder catheterisation, Bone scan normal
Clinical narrative: Narrative: 96 yo patient who was treated for urinary retention, AKI, and acute COVID 19 infection. The patient remained asymptomatic with COVID 19 and was placed on contact and droplet precautions. He was seen by Urology and started on Finasteride and Tamsulosin. It was noted in the chart that the patient's PSA gradually increased through the course of the last five years. Repeat PSA was 101. UA was negative for bacterial growth. The patient remained afebrile. Renal u/s and CT abd/pelvis revealed 8.2 cm enlarged prostate. The patient underwent nuclear bone scan which was negative for neoplasm. Urology plans to complete Eligard injection within two weeks post discharge for enlarged prostate. The patient will keep foley catheter in place and allow bladder rest for 2-4 weeks. The patient will resume ASA at 81 mg po daily given history of CAD and not 325 mg po daily.The patient's hematuria cleared without recurrence and hgb remained stable. The patient was medically stable for discharge on 12/30/21 and left hospital without incidence.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Haematuria, Haemoglobin, Prostatic specific antigen increased, Prostatomegaly
Clinical narrative: Narrative: 96 yo patient who was treated for urinary retention, AKI, and acute COVID 19 infection. The patient remained asymptomatic with COVID 19 and was placed on contact and droplet precautions. He was seen by Urology and started on Finasteride and Tamsulosin. It was noted in the chart that the patient's PSA gradually increased through the course of the last five years. Repeat PSA was 101. UA was negative for bacterial growth. The patient remained afebrile. Renal u/s and CT abd/pelvis revealed 8.2 cm enlarged prostate. The patient underwent nuclear bone scan which was negative for neoplasm. Urology plans to complete Eligard injection within two weeks post discharge for enlarged prostate. The patient will keep foley catheter in place and allow bladder rest for 2-4 weeks. The patient will resume ASA at 81 mg po daily given history of CAD and not 325 mg po daily.The patient's hematuria cleared without recurrence and hgb remained stable. The patient was medically stable for discharge on 12/30/21 and left hospital without incidence.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound kidney abnormal, Urinary retention, Urine analysis normal
Clinical narrative: Narrative: 96 yo patient who was treated for urinary retention, AKI, and acute COVID 19 infection. The patient remained asymptomatic with COVID 19 and was placed on contact and droplet precautions. He was seen by Urology and started on Finasteride and Tamsulosin. It was noted in the chart that the patient's PSA gradually increased through the course of the last five years. Repeat PSA was 101. UA was negative for bacterial growth. The patient remained afebrile. Renal u/s and CT abd/pelvis revealed 8.2 cm enlarged prostate. The patient underwent nuclear bone scan which was negative for neoplasm. Urology plans to complete Eligard injection within two weeks post discharge for enlarged prostate. The patient will keep foley catheter in place and allow bladder rest for 2-4 weeks. The patient will resume ASA at 81 mg po daily given history of CAD and not 325 mg po daily.The patient's hematuria cleared without recurrence and hgb remained stable. The patient was medically stable for discharge on 12/30/21 and left hospital without incidence.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative: Patient reports "headache that will not go away since vaccine. to have MRI this week. Tha's the only symptom so far." Patient instructed to monitor for the following symptoms over the course of three weeks after the vaccination. * A headache that occurs 6 days or more after vaccination * A headache that is different from other headache you have had * Confusion or trouble thinking clearly * Visual changes, such as blurry vision * Weakness, numbness, or trouble moving one or more parts of your body, trouble speaking or seizures * Tiny spots under the skin away from the area where you had the infection (this is a sign of low platelets) Patient instructed to contact their health care provider if one or more of these symptoms develop. If symptoms are severe, seek immediate medical attention at the closest emergency department or call 9-1-1
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative:  Patient reported headache following administration of 1st of Moderna Covid vaccine. Patient required no intervention and was able to depart home with no trouble.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Narrative: Patient developed chest pain following first dose of Pfizer covid vaccine. Patient was sent to outside emergency department for follow up. No additional information available. Patient later notes indicate no poor outcomes.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for Covid-19 and was hospitalized despite full vaccination. Received Pfizer 1 and 2, and booster received 11/16/2021, hospitalized 11/26/2021
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot
Clinical narrative: Patient reported feeling warm all over following 1st  Moderna Covid vaccine. Resolved within 15 minutes without  intervention.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative: Patient reported he was concerned because he had a headache on Saturday the 4/16, 10 days after the vaccine. He sated it was "behind my eye" and he does not have headaches like that. He did report that the headache resolved the next morning on the 4/17.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Narrative: Patient developed a headache and nausea shortly after receiving their second dose of Pfizer covid vaccine. Patient required no additional intervention and was able to leave without issue.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Death, Decreased appetite, Leg amputation, Peripheral vascular disorder
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Medical examination determined he died of natural causes. Patient had a below knee amputation due to peripheral vascular disease. In February 2021 leading up until his death on 3/10/21 he was noted to have poor appetite and significant weight loss. Nothing else in the chart indicative of a potential cause of death.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Medical examination determined he died of natural causes. Patient had a below knee amputation due to peripheral vascular disease. In February 2021 leading up until his death on 3/10/21 he was noted to have poor appetite and significant weight loss. Nothing else in the chart indicative of a potential cause of death.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Patient reported nausea following 1st dose administration of moderna covid vaccine. Nausea resolved without intervention.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Fall, Haematoma, Rhabdomyolysis
Clinical narrative: Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted on 2/4/21 with rhabdomyolysis and a hematoma after a a fall. Details surrounding his death on 2/16/21 uncertain due to admission at non-facility. Comorbidities include CHF, anemia, history of stroke, traumatic brain injury, and aortic aneurysm.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Narrative:  Patient reports that he has " felling of a limb that is asleep, i have full strength but it feels like it is trying to wake up, since the vaccination."" i excersise daily." Patient was refered to PCP, and to seek further attention if it does not improve or gets worse. There was no documentation to his provider prior to this. Patient instructed to monitor for the following symptoms over the course of three weeks after the vaccination. * A headache that occurs 6 days or more after vaccination * A headache that is different from other headaches you have had * Confusion or trouble thinking clearly * Visual changes, such as blurry vision * Weakness, numbness, or trouble moving one or more parts of your body of your body, trouble speaking or seizures * Tiny spots under the skin away from the area where you had the infection (this is a sign of low platelets) Patient instructed to contact their health care provider if one or more of these symptoms develop. symptoms are severe, seek immediate medical attention at the closest emergency department or call 9-1-1
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for Covid-19 and was hospitalized despite full vaccination of Pfizer 1&2, 2nd dose on 0/23/2021. No booster was received. Admitted 11/23/21.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient reported lightheadedness without other symptoms that resolved spontaneously. No intervention needed.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative:  Patient developed lightheadedness after receiving first dose of moderna covid vaccination.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient tested positive for Covid-19 and was hospitalized on 11/23/2021 despite the full vaccination of J&J on 8/30/2021. No booster received.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Artificial crown procedure, Central venous catheterisation, Dental care, Endodontic procedure, Swelling face
Clinical narrative: Narrative: presents for second dose of Moderna vaccine. His wife states that he had facial swelling four days after the injection which was given 1/14/21. He is also a dialysis patient with a tempory port. They did not report to healthcare provider. Dialysis thought the reaction may be the temporary port? Dental work also last summer -2 crowns and a root canal. He is on 3 meds that could potentially cause this issue.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Aphasia, Cerebrovascular accident, Neurological symptom
Clinical narrative: Narrative:  Daughter stated that pt had a "stroke" on March 15th. She stated that he has been in local hospitals and rehab. She stated he cannot speak and has other symptoms also. She stated "he has lots of those symptoms." She did state he has not had a seizure or had spots under his skin that she is aware of but is on blood thinners.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Palpitations, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Narrative: She reports having experienced palpitation and rash after the initial vaccination: *Palpitation: began the day after vaccination and occured intermittently for another 2 days - 4x episodes of <10 seconds each in total. A/w slight dizziness, but no pain, disorientation, syncope, weakness, nausea/vomiting. She notes having similar episodes in college and being diagnozed with "angina pectoris" at that time. She was not placed on any medications and did not go some sore of cardiac procedure (such as PCI) at that time. No known FHx of arrhythmias. Sister with reported congenital valvular issue. *Rash: began 13 days after vaccination, largest size described as circular/well circumscribed with ~2.3-3inches in diameter. Associated with induration, erythema, warmth to touch, mild pruritus. NO associated sloughing. The rash spontaneously resolved after a week. Only therapy applied was ice.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Skin induration, Skin warm
Clinical narrative: Narrative: She reports having experienced palpitation and rash after the initial vaccination: *Palpitation: began the day after vaccination and occured intermittently for another 2 days - 4x episodes of <10 seconds each in total. A/w slight dizziness, but no pain, disorientation, syncope, weakness, nausea/vomiting. She notes having similar episodes in college and being diagnozed with "angina pectoris" at that time. She was not placed on any medications and did not go some sore of cardiac procedure (such as PCI) at that time. No known FHx of arrhythmias. Sister with reported congenital valvular issue. *Rash: began 13 days after vaccination, largest size described as circular/well circumscribed with ~2.3-3inches in diameter. Associated with induration, erythema, warmth to touch, mild pruritus. NO associated sloughing. The rash spontaneously resolved after a week. Only therapy applied was ice.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea
Clinical narrative: Patient reports increasing SOB but states that he has been SOB for  years. Unknown if increasing SOB is related to vaccine. He stated he uses two  inhalers and will notify his PCP with any additional concerns. Patient verbalized  understanding to go to nearest emergency department or call 9-1-1 if his SOB  increases more or he thinks he needs medical attention. Patient reports no other  signs and symptoms currently. Patient instructed to monitor for the following  symptoms over the course of three weeks after the vaccination. * A headache that  occurs 6 days or more after vaccination * A headache that is different from other  headaches you have had * Confusion or trouble thinking clearly * Visual changes,  such as blurry vision * Weakness, numbness, or trouble moving one or more parts  of your body of your body, trouble speaking or seizures * Tiny spots under the skin  away from the area where you had the infection (this is a sign of low platelets)  Patient instructed to contact their health care provider if one or more of these  symptoms develop. If symptoms are severe, seek immediate medical attention at  the closest emergency department or call 9-1-1
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient died under hospice care on 3/6/21. Cause of death unknown as care was not being provided by the facility. PMH not current in system.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Narrative: Patient's daughter called 4/15/21 stating Patient is c/o of both of his arms hurting "from the Johnson and Johnson vaccination". She said he thinks he "has a blood clot". Patient received Vaccine MARCH 18th in Rt Deltoid. Notified PCP. Patient advised to go to ER if he believes he is having a blood clot. Verbalized understanding. On 4/19: Message left for Patient to monitor for the following symptoms over the course of three weeks after the vaccination. * A headache that occurs 6 days or more after vaccination * A headache that is different from other headaches you have had * Confusion or trouble thinking clearly * Visual changes, such as blurry vision * Weakness, numbness, or trouble moving one or more parts of your body of your body, trouble speaking or seizures * Tiny spots under the skin away from the area where you had the infection (this is a sign of low platelets) Patient instructed to contact their health care provider if one or more of these symptoms develop. If symptoms are sever, seek immediate medical attention at the closet emergency department of call 9-1-1
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Chills, Fatigue, Productive cough
Clinical narrative: Narrative: COVID POSITIVE TEST AFTER COMPLETION OF COVID-19 VACCINE SERIES, ASYMPTOMATIC 01/13 COVID vaccine dose #1 02/04 COVID vaccine dose #2 04/13 tested for COVID for pre-procedure, no symptoms, tested positive 04/14 asymptomatic 04/15 low grade fever with slight chills, taking tylenol, hip pain 04/16 o2 sat94% room air, temp 99 after tylenol, cills resolved 04/17 cough more productive, yellow tinged sputum, o2 sat 97% RA 047/18 less hip pain, fatigue improved 04/19 continues to improve
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Narrative: COVID POSITIVE TEST AFTER COMPLETION OF COVID-19 VACCINE SERIES, ASYMPTOMATIC 01/13 COVID vaccine dose #1 02/04 COVID vaccine dose #2 04/13 tested for COVID for pre-procedure, no symptoms, tested positive 04/14 asymptomatic 04/15 low grade fever with slight chills, taking tylenol, hip pain 04/16 o2 sat94% room air, temp 99 after tylenol, cills resolved 04/17 cough more productive, yellow tinged sputum, o2 sat 97% RA 047/18 less hip pain, fatigue improved 04/19 continues to improve
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Dementia, Fall, Head injury
Clinical narrative: Narrative: Patient had a COVID positive test on 3/1/21. He did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 87 and went to the ER on 2/21/21 for a fall resulting in a vertebral fracture. Patient lives in an assisted living facility and continued to have subsequent falls including one resulting in a head injury. Patient also had advanced dementia and eventually required hospice care up until he passed on 3/9/21.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Spinal fracture
Clinical narrative: Narrative: Patient had a COVID positive test on 3/1/21. He did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 87 and went to the ER on 2/21/21 for a fall resulting in a vertebral fracture. Patient lives in an assisted living facility and continued to have subsequent falls including one resulting in a head injury. Patient also had advanced dementia and eventually required hospice care up until he passed on 3/9/21.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Nasal congestion, Pain
Clinical narrative: Narrative: Patient diagnosed with COVID infection after completion of COVID- 19 vaccine and after exposure to his wife, who was ill with COVID infection first.  01/11 COVID vaccine dose #1 02/01 COVID vaccine dose #2 04/15 pt reported  symptoms related to covid: fever, cough, nasal congestion, feels achy 04/16 COVID positive test
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient diagnosed with COVID infection after completion of COVID- 19 vaccine and after exposure to his wife, who was ill with COVID infection first.  01/11 COVID vaccine dose #1 02/01 COVID vaccine dose #2 04/15 pt reported  symptoms related to covid: fever, cough, nasal congestion, feels achy 04/16 COVID positive test
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Chronic obstructive pulmonary disease, Computerised tomogram thorax normal, Condition aggravated
Clinical narrative: Admissions diagnosis: Acute hypoxic Respiratory failure Admitted 12/28/21 - 12/29/21. 77-year-old male with a past medical history significant for non-small cell adenocarcinoma of the lung s/p chemotherapy/XRT now on immunotherapy, COPD, moderate aortic stenosis, HTN, HLD, BPH who presents with acute hypoxic respiratory failure secondary to COVID-19, receiving booster 9/29/2021. He has no known exposure to COVID-19, however to found to have AHRF with exertion in ED with desaturation to 88%. Also suspect concurrent COPD exacerbation with his hemoptysis and increased albuterol use. Immunotherapy pneumonitis possible but no evidence of pneumonitis on CT chest on admission. No PE or lung infiltrates noted on CT chest. Patient was treated with dexamethasone 6mh daily and remdesivir 200 IV x1 and then 100 IV daily, as well as azithromycin 500mg IV daily. On discharge, patient was satting well on Room Air, and walk test was within normal limits. Vaccination history: Date Immunization Series 09/29/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCH/0 3 02/27/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 3 02/06/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/01
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Admissions diagnosis: Acute hypoxic Respiratory failure Admitted 12/28/21 - 12/29/21. 77-year-old male with a past medical history significant for non-small cell adenocarcinoma of the lung s/p chemotherapy/XRT now on immunotherapy, COPD, moderate aortic stenosis, HTN, HLD, BPH who presents with acute hypoxic respiratory failure secondary to COVID-19, receiving booster 9/29/2021. He has no known exposure to COVID-19, however to found to have AHRF with exertion in ED with desaturation to 88%. Also suspect concurrent COPD exacerbation with his hemoptysis and increased albuterol use. Immunotherapy pneumonitis possible but no evidence of pneumonitis on CT chest on admission. No PE or lung infiltrates noted on CT chest. Patient was treated with dexamethasone 6mh daily and remdesivir 200 IV x1 and then 100 IV daily, as well as azithromycin 500mg IV daily. On discharge, patient was satting well on Room Air, and walk test was within normal limits. Vaccination history: Date Immunization Series 09/29/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCH/0 3 02/27/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 3 02/06/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/01
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Glycosylated haemoglobin increased, Hyperglycaemia
Clinical narrative: Narrative: 82 yo gentleman with hx of CAD s/p MI, s/p LAD stent, chronic afib, moderate AS, COPD, Type II DM, who presented on 12/29/21 with acute hypoxic respiratory failure due to COVID-19. He was admitted to the medical floor on airborne precautions and was started on decadron,remdesivir and oxygen. The patient improved clinically, he was evaluated by Home 02 who recommended 2 liters of 02. Patient with Type II DM, A1c 7.3 on metformin as an outpt. Metformin was held on admission. Pt with hyperglycemia due to decadron use, lantus was started during this hospitalization. Patient declined to take insulin at discharge, stating that he would resume metformin. He is agreeable to checking fsbs 2XD ( steroids will not be continued post discharge).
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Anion gap, Anticoagulant therapy, Aortic arteriosclerosis
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriosclerosis coronary artery, Aspartate aminotransferase increased, Basophil count decreased, Basophil percentage, Blood albumin decreased
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase, Blood bilirubin normal, Blood calcium decreased, Blood chloride normal, Blood creatinine increased
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood urea normal, Blood urine absent
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Carbon dioxide normal, Cerebral atrophy, Chest X-ray abnormal
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cholelithiasis, Computerised tomogram head abnormal, Computerised tomogram thorax abnormal, Electrocardiogram
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Eosinophil count decreased, Eosinophil percentage decreased, Fall, Gastritis erosive, Gastrointestinal haemorrhage
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate decreased, Glucose urine absent, Granulocyte count, Granulocyte percentage, Haematocrit decreased
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Haemostasis, Injury, Liver function test increased, Lung disorder
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Lung hernia, Lymphocyte count decreased, Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume normal, Mean platelet volume decreased, Monocyte count normal, Monocyte percentage increased, Neurological examination
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge